LONDON, Feb. 26, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that Justin Gover, GW's Chief Executive Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on Monday, 3 March, 2014 at 3:30 p.m. ET. The conference will be held at the Boston Marriott Copley Place.
Help employers find you! Check out all the jobs and post your resume.
